Lung Cancer
News
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
Conference Coverage
Higher death rate seen in cancer patients with nosocomial COVID-19
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...
News
Heavy toll from ongoing cancer referral delays
Conference Coverage
ctDNA clearance tracks with PFS in NSCLC subtype
The median progression-free survival was significantly longer for patients with circulating tumor DNA clearance.
Conference Coverage
Personalized cancer vaccine may enhance checkpoint inhibitor activity
Conference Recap
Highlights in Non–Small Cell Lung Cancer From ASCO 2020
Dr. Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody‒...
Conference Coverage
Immunotherapy combo improves ORR, PFS in PD-L1+ NSCLC
Adding tiragolumab to atezolizumab led to “clinically meaningful” improvements in patients with PD-L1–positive non–small cell lung cancer.
Conference Coverage
No OS benefit with gefitinib vs. chemo for EGFR+ NSCLC
Adjuvant gefitinib improved disease-free survival, but not overall survival, when compared with standard chemotherapy.
Article
Pulmonary Neuroendocrine Tumor Presenting as a Left Pleural Effusion
The presence of a symptomatic and recurrent unilateral pleural effusion should alert physicians to consider thoracentesis with mindful use of...
